1100 13th Street, NW, Suite 750Washington, DC 20005202.887.6400Toll-free: 800.544.0155
All Contents © 2016The Kiplinger Washington Editors
See All Authors »
Kiplinger's Personal Finance
Feinberg manages a New York City-based hedge fund called CJA Partners.
Now I plan to invest a chunk of the family portfolio in index funds—oh, the horror!
See More From: Promised Land
Don't let a stock's stumbles blind you to its long-term potential.
Seth Klarman was prescient in recognizing that the genomics revolution would supercharge the biotech industry.
When investors like Carl Icahn and Bill Ackman turn the heat on management, shareholders stand to benefit.
Buying more shares makes sense when nothing about a company has changed except the price of its stock.
Bank of America has made great progress in cutting costs and settling legal claims for shoddy mortgage securities.
What I like about BioDelivery Sciences is not so much that there are many ways to win as that there are almost no ways to lose.
Learn from the Kahns, ultra-patient (and successful) value investors who often hold stocks for 20 years.
If you really know a company's value, you can relax no matter how high the stock goes.
These opposites are both attractive.
Atop the corruption is a level of hypocrisy that is tough to stomach.
Bank of America's stock could reach $20 over the next year without breaking a sweat.
Good investors have a talent for focusing on the facts that matter most. Bad investors do not.
For long-term stock market bulls, the sluggish economy of the Obama years is actually a plus.
The industry has been historically turbulent, but those past problems may present opportunities today.
It takes an enormous shock to trigger runaway inflation, such as a war or a general economic collapse.
From poor CEO choices to near-constant dissension among directors, HP keeps hitting new lows.